Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique

Bone Marrow Transplantation

Volumn 29, Issue 4, 2002, Pages 335-339

  Meijer, E ^a   Slaper Cortenbach, I C M ^a   Thijsen, S F T ^a   Dekker, A W ^a   Verdonck, L F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

B cell depletion; BMT; Epstein Barr virus associated lymphoproliferative disorders (EBV LPD); MUD; T cell depletion

Indexed keywords

AMPHOTERICIN B; CD19 ANTIGEN; CD2 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; CEFALOTIN; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; MONOCLONAL ANTIBODY; SOYBEAN AGGLUTININ; THYMOCYTE ANTIBODY; VALACICLOVIR;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INFECTION RISK; INTERMETHOD COMPARISON; LEUKEMIA; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; T LYMPHOCYTE; VIRUS INFECTION; VIRUS TRANSMISSION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD2; ANTIGENS, CD22; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL ADHESION MOLECULES; EPSTEIN-BARR VIRUS INFECTIONS; ERYTHROCYTES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LECTINS; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PLANT LECTINS; SHEEP; SOYBEAN PROTEINS; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036124989     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703362     Document Type: Article

References (18)

1. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program
2. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: An EBMT study
3. Graft-versus-host disease
4. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-insitutional study
5. Bone marrow transplantation
6. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft
7. A risk adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplantation
8. Transplantation for acute leukemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells
9. The depletion of T cells from haematopoietic stem cell transplants
10. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
11. Potent effects of ATG used as part of the conditioning in matched unrelated donor transplantation
12. Epstein-Barr virus infection
13. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: Implications for sites of viral latency
14. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients
15. Prevention of EBV-induced Blymphoproliferative disorder by ex vivo marrow B cell depletion in HLA-phenoidentical or non-identical T depleted bone marrow transplantation
16. Addition of B cell depletion of donor marrow with anti-CD20 antibody to a T cell depletion regimen for prevention of EBV lymphoma after bone marrow transplantation
17. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T cell-depleted marrow transplants
18. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T cell depleted SCT